EVOFEM BIOSCIENCES INC's ticker is EVFM and the CUSIP is 30048L104. A total of 2 filers reported holding EVOFEM BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,183,000 | -15.3% | 6,419,245 | -6.4% | 0.00% | – |
| Q4 2021 | $2,576,000 | -50.3% | 6,860,966 | -2.1% | 0.00% | – |
| Q3 2021 | $5,178,000 | -34.6% | 7,009,858 | 0.0% | 0.00% | – |
| Q2 2021 | $7,921,000 | +8.7% | 7,009,858 | +68.3% | 0.00% | – |
| Q1 2021 | $7,288,000 | -15.9% | 4,164,781 | +15.8% | 0.00% | – |
| Q4 2020 | $8,667,000 | +5.9% | 3,596,489 | +3.7% | 0.00% | – |
| Q3 2020 | $8,188,000 | +13.9% | 3,469,516 | +36.5% | 0.00% | – |
| Q2 2020 | $7,191,000 | +116.7% | 2,541,403 | +307.3% | 0.00% | – |
| Q1 2020 | $3,318,000 | +29.7% | 623,920 | +50.5% | 0.00% | – |
| Q4 2019 | $2,558,000 | +21.5% | 414,612 | -0.8% | 0.00% | – |
| Q3 2019 | $2,105,000 | -51.8% | 417,808 | -36.5% | 0.00% | – |
| Q2 2019 | $4,370,000 | +311.1% | 658,091 | +116.7% | 0.00% | – |
| Q1 2019 | $1,063,000 | -7.5% | 303,683 | +10.7% | 0.00% | – |
| Q4 2018 | $1,149,000 | +30.7% | 274,437 | +26.4% | 0.00% | – |
| Q3 2018 | $879,000 | – | 217,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mirador Capital Partners LP | 2,807,681 | $955,000 | 0.19% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 1,100,000 | $374,000 | 0.13% |
| JB CAPITAL PARTNERS LP | 23,184 | $118,000 | 0.03% |
| Westside Investment Management, Inc. | 10,000 | $2,974,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 47,103 | $3,067,000 | 0.01% |
| Platform Technology Partners | 13,000 | $4,000 | 0.00% |
| Bayesian Capital Management, LP | 35,900 | $12,000 | 0.00% |
| RBF Capital, LLC | 69,551 | $25,000 | 0.00% |
| HAP Trading, LLC | 20,100 | $22,000 | 0.00% |
| Advisor Resource Council | 10,000 | $3,000 | 0.00% |